Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral…
<!-- Name:DistributionId Value:8794062 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Nonviral
Muscular Dystrophy Association’s Venture Philanthropy Program Announces Investment in…
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announces a $650,000 investment in Myosana Therapeutics via its MDA Venture Philanthropy (MVP)…
The viral vector, non-viral vector and gene therapy manufacturing market is projected…
London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market,…
Tissue nanotransfection technology proves useful in non-viral topical gene editing to…
The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine technology that…
COVID-19 nasal vaccine candidate effective at preventing disease transmission, study…
Breathe in, breathe out. That's how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in developing intramuscular…